HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 35 filers reported holding HEPION PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,244,552 | +159.4% | 1,602,772 | +0.3% | 0.00% | – |
| Q4 2022 | $479,748 | -40.4% | 1,597,566 | +0.3% | 0.00% | – |
| Q3 2022 | $805,000 | -12.9% | 1,592,781 | -1.4% | 0.00% | – |
| Q2 2022 | $924,000 | -55.6% | 1,614,716 | +0.1% | 0.00% | – |
| Q1 2022 | $2,080,000 | +12.4% | 1,612,627 | -0.7% | 0.00% | – |
| Q4 2021 | $1,850,000 | -26.0% | 1,623,905 | -0.6% | 0.00% | – |
| Q3 2021 | $2,500,000 | -23.5% | 1,634,012 | -1.0% | 0.00% | – |
| Q2 2021 | $3,266,000 | +3.4% | 1,649,929 | -3.9% | 0.00% | – |
| Q1 2021 | $3,158,000 | +20.7% | 1,716,168 | +43.7% | 0.00% | – |
| Q4 2020 | $2,616,000 | +1284.1% | 1,194,434 | +1867.1% | 0.00% | – |
| Q3 2020 | $189,000 | +9.2% | 60,722 | 0.0% | 0.00% | – |
| Q2 2020 | $173,000 | +61.7% | 60,722 | 0.0% | 0.00% | – |
| Q1 2020 | $107,000 | -67.1% | 60,722 | 0.0% | 0.00% | – |
| Q4 2019 | $325,000 | – | 60,722 | +57184.9% | 0.00% | – |
| Q3 2019 | $0 | – | 106 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 57,309 | $178,000 | 0.03% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 15,552 | $48,000 | 0.00% |
| Squarepoint Ops LLC | 15,524 | $48,000 | 0.00% |
| ExodusPoint Capital Management, LP | 11,632 | $36,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 33,215 | $103,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 57 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 15,786 | $49,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 29,233 | $91,000 | 0.00% |
| MORGAN STANLEY | 54 | $0 | 0.00% |